William W. Busse

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 2.1K citations

Public Health, Pharmacotherapy, Allergy +16

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Mario Castro, Jonathan Corren, Ian Pavord et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text

Pharmacy, Immunology, Pharmacology +13

An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

Helen K. Reddel, D. Robin Taylor, Eric D. Bateman et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 1.9K citations

Medicine, Pediatrics, Pediatric Pulmonology +12

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair et al. · The Lancet · 2016 · 1.4K citations

Pharmacy, Immunology, Pharmacology +17

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

Life Sciences, Immunology, Pharmacology +16